1. Introduction {#S1}
===============

Approximately 30% of the world\'s population is infected with *Mycobacterium tuberculosis* (*Mtb*), the causative agent of tuberculosis (TB). TB is the leading cause of human deaths globally from an infectious disease and is responsible for approximately 1.4 million deaths annually \[[@R9]\]. The capability of *Mtb* to acclimatize and counteract killing by the immune system facilitates its survival, replication, and long-term persistence. In this context, it has been shown that *Mtb* successfully senses and responds to host generated antimicrobial redox stresses such as reactive oxygen and nitrogen species (ROS and RNS). Impaired ability of mice lacking NADPH oxidase (NOX2) and nitric oxide synthase (iNOS) in controlling *Mtb* proliferation signifies the centrality of ROS and RNS in regulating TB infection \[[@R10],[@R29],[@R57]\]. Furthermore, children with defective NOX2 remain highly susceptible to TB infection \[[@R25]\].

Several studies have indicated that *Mtb* harbors sophisticated systems to continuously monitor and mount appropriate responses against host generated redox stresses. *Mtb* is known to mobilize several transcriptional regulators in response to ROS and RNS. For example, *Mtb* coordinates transcriptional response to oxido-reductive stress *via* activating sigma factors (SigH and SigE), two-component systems (SenX-RegX and DosR/S/T), serine-threonine kinase (PknG), and transcriptional regulators (MosR, Rv2745c, HpoR, and LtmA) \[[@R16],[@R2],[@R23],[@R24],[@R26],[@R30],[@R36],[@R43]\]. Additionally, *Mtb* encodes seven members of WhiB family (WhiB1 to WhiB7) of redox-sensing transcription factors. These proteins are characterized by conserved Cys residues (Cys-X~n~-Cys-X~2~-Cys-X~5~-Cys; where X is an amino acid and n is a variable number) that coordinate an Fe--S cluster \[[@R14]\]. Till date, WhiB proteins in mycobacteria have been reported to carry out diverse functions such as maintaining redox homeostasis (WhiB3, WhiB4 and WhiB7), regulating secretion systems (WhiB1, WhiB5 and WhiB6), virulence (WhiB3, WhiB4, WhiB5 and WhiB6), antibiotic resistance (WhiB7) and reactivation from dormancy (WhiB1 and WhiB5) \[[@R4],[@R41],[@R42],[@R44],[@R5],[@R7],[@R8]\]. Among all WhiB proteins, WhiB3 is the most widely studied. WhiB3 has been shown to influence *Mtb* pathogenesis by modulating host pathology, phagosomal-maturation, and cell-cycle \[[@R11],[@R32],[@R41],[@R48]\]. Furthermore, WhiB3 has been recently shown to protect *Mtb* from acidic stress encountered inside macrophages by maintaining the redox potential of it\'s cytoplasmic redox buffer, mycothiol (MSH) \[[@R32]\].

Despite the great strides made in our understanding of the function of WhiB3 in *Mtb*, several gaps still exist. For example, studies have shown that WhiB3 iron-sulfur cluster is sensitive to oxidation and nitrosylation \[[@R42]\]. Atmospheric oxygen directly targets WhiB3 \[4Fe-4S\]^2+^ cluster to generate a \[3Fe-4S\]^+^ intermediate followed by a complete loss of Fe-S cluster. On the other hand, NO forms a protein-bound dinitrosyl--iron--dithiol complex (DINC) with the \[4Fe-4S\]^2+^ cluster of WhiB3 \[[@R42]\]. These results implicate WhiB3 in sensing and responding to oxidative and nitrosative conditions in *Mtb*. In other bacteria, Fe-S cluster transcription factors such as SoxR and FNR have been shown to be the primary sensors of NO and O~2~ coordinating metabolic adaptation under redox stress conditions \[[@R17]\]. However, a clear FNR-or SoxR -like protein is absent in *Mtb*. Therefore, it was proposed that WhiB3 functions as one of the crucial "redox sensors" involved in the adaptation of *Mtb* in response to ROS and RNS. In line with this, hydrogen peroxide (H~2~O~2~) and nitric oxide (NO) are known to up-regulate *whiB3* expression in *Mtb* ([@R55]). Nevertheless, experimental evidences directly linking the role of WhiB3 in mediating mycobacterial adaptation to oxidative and/or nitrosative stress are lacking. Filling this knowledge gap will be crucial to firmly establish the role of WhiB3 as an intracellular redox sensor and a virulence regulator in *Mtb*.

In this study, we measured the dynamic changes in the cytoplasmic redox potential of wt *Mtb* and *Mtb*Δ*whiB3* in response to oxidative and nitrosative stresses *in vitro*. Furthermore, we performed survival experiments to assess the requirement of WhiB3 in mitigating stress induced by ROS and RNS. Lastly, we assessed the potential of wt *Mtb* and *Mtb*Δ*whiB3* to survive inside RAW264.7 macrophages and in inducing early granuloma development using the human PBMCs *in vitro*.

2. Results {#S2}
==========

2.1. *Mtb* WhiB3 is required to survive in response to ROS and RNS {#S3}
------------------------------------------------------------------

To examine if WhiB3 is required to tolerate oxidative stress, we first exposed *wt Mtb*, *Mtb*Δ*whiB3*, and *whiB3 Comp* strains to a potent oxidant cumene hydroperoxide (CHP). The organic hydroperoxide such as CHP stimulates the production of the free radical intermediates peroxyl and alkoxyl radicals, which can permeate biological membranes and triggers the generation of hydroxyl radical \[[@R20]\]. Also, CHP is more hydrophobic than H~2~O~2~ and is known to induce lipid peroxidation as a redox-based mechanism to damage cell membrane \[[@R21]\]. The *Mtb* strains were exposed to non-lethal (10 μM), sub-lethal (50 μM), and lethal (100 μM) concentrations of CHP for 24 h and 48 h and survival was determined by enumerating viable bacteria. At 10 μM CHP, *Mtb*Δ*whiB3* survived equivalent to wt *Mtb* levels at 24 and 48 h, post-exposure ([Fig. 1A](#F1){ref-type="fig"}). However, an \~10 to \~ 70 -fold reduction in *Mtb*Δ*whiB3* survival as compared to wt *Mtb* was detected upon treatment with 50 and 100 μM CHP at 24 and 48 h, post-exposure, respectively ([Fig. 1A](#F1){ref-type="fig"}). Restoration of *whiB3* expression in *Mtb*Δ*whiB3* fully complemented the oxidative stress survival defect ([Fig. 1A](#F1){ref-type="fig"}). Additionally, we examined survival in response to 1 mM (non-lethal) and 5 mM H~2~O~2~ (sub-lethal) over time. While all there strains grew similarly at 1 mM H~2~O~2~ ([Fig. 1B](#F1){ref-type="fig"}), *Mtb*Δ*whiB3* showed reduced survival upon exposure to 5 mM H~2~O~2~ as compared to wt *Mtb* and *whiB3 Comp* strains ([Fig. 1C](#F1){ref-type="fig"}).

One of the major antimicrobial stresses induced by immune-activated macrophages include nitric oxide (NO) generated by iNOS. At acidic pH of 5.5 prevailing inside activated macrophages \[[@R39]\], nitrite (NO~2~^−^), which is a major oxidation product of NO protonates to form nitrous acid (HNO~2~). The HNO~2~ further dismutases to form other RNS such as NO~2~ \[[@R49]\]. These RNS inflict nitrosative stress by binding to metal, nitrosylating cysteines, and nitration of tyrosine residues in proteins \[[@R46],[@R47]\]. Also, NO can react with low molecular weight (LMW) thiols such as mycothiol (MSH) to form S-nitrosomycothiols \[[@R54]\]. Studies have shown that RNS generated by acidified nitrite can affect *Mtb* survival by inactivating proteins involved in the metabolism and in antioxidant defense (lipoamide dehydrogenase and proteasome ATPase) *via* S-nitrosylation during infection \[[@R12],[@R38]\]. Additionally, RNS oxidize cysteine thiols of some of the *Mtb* proteins to form mixed intermolecular disulfide \[[@R38]\]. The RNS generated by acidified nitrite not only induces nitrosative but also cause oxidative injury. For example, NO combines with superoxide from bacterial metabolism to generate peroxynitrite anion (OONO−), which is a potent oxidant of methionine (Met) residues in proteins, disrupts Fe-S clusters, nitrate tyrosine residues, and oxidize cysteines \[[@R35],[@R45],[@R46]\].

Given the fact that WhiB3 4Fe-4S cluster reacts with NO \[[@R42]\] and that OONO− oxidizes Fe-S clusters \[[@R45],[@R51]\], we next investigated if WhiB3 protects *Mtb* from RNS. To mimic physiologically relevant conditions, we exposed wt *Mtb*, *Mtb*Δ*whiB3*, and *whiB3 Comp* strains to 0.5 mM sodium nitrite at pH 5.5 (acidified nitrite), which is well known to induce nitrosative stress in *Mtb* without inducing significant killing \[[@R3]\]. As shown in [Fig. 1B](#F1){ref-type="fig"}, acidified NaNO~2~ induces bacteriostasis in wt *Mtb* at 48 h post-exposure and killing at 96 h post-exposure as compared to unstressed bacteria. In contrast, \~15- and \~200- fold reduced survival of *Mtb*Δ*whiB3* as compared to wt *Mtb* was observed at 48 and 96 h, post-treatment, respectively ([Fig. 1D](#F1){ref-type="fig"}). As expected, complementation of *whiB3* restored wt *Mtb* growth phenotype in response to acidified NaNO~2~ ([Fig. 1D](#F1){ref-type="fig"}). Because activated macrophages have the ability to generate ONOO− \[[@R33]\], we tested the antimicrobial activity of ONOO− on the survival of wt *Mtb*, *Mtb*Δ*whiB3*, and *whiB3 Comp* strains. While wt *Mtb* and *whiB4* Comp showed marginal sensitivity to 50 μM of ONOO− ([Fig. 1E](#F1){ref-type="fig"}), *Mtb*Δ*whiB3* was relatively more sensitive to ONOO− ([Fig. 1E](#F1){ref-type="fig"}). These findings are in line with an earlier report demonstrating remarkable resistance displayed by the virulent *Mtb* strains towards ONOO− \[[@R58]\]. Our results indicate that WhiB3 is likely to be one of the factors contributing towards ONOO− resistance in *Mtb*.

Since *Mtb* encounters ROS and RNS stresses inside macrophages, we assessed the growth of *Mtb*Δ*whiB3* inside murine macrophage cell line RAW 264.7. Wt *Mtb*, *Mtb*Δ*whiB3*, and *whiB3* Comp strains were used to infect RAW 264.7 cells (MOI = 2) and growth was monitored over time by enumerating CFUs. As shown in [Fig. 1C](#F1){ref-type="fig"}, *Mtb*Δ*whiB3* showed growth comparable to wt *Mtb* at day 0 (*i.e.* 4 h, post-infection). However, while wt *Mtb* grew exponentially at later time points, *Mtb*Δ*whiB3* did not show any appreciable increase in growth overtime ([Fig. 1F](#F1){ref-type="fig"}). Furthermore, *whiB3 Comp* strain displayed the growth phenotype comparable to wt *Mtb* ([Fig. 1F](#F1){ref-type="fig"}).

2.2. *Mtb* WhiB3 maintains redox homeostasis in response to ROS and RNS {#S4}
-----------------------------------------------------------------------

To examine if WhiB3 maintains redox homeostasis in response to ROS/RNS stress, we determined dynamic changes in mycobacterial redox state using a highly sensitive and specific biosensor of mycothiol (MSH) redox potential (*E~MSH~;* Mrx1-roGFP2) in wt *Mtb* \[[@R1]\]. In Mrx1-roGFP2, oxidation-reduction sensitive GFP (roGFP2) was genetically fused to MSH-specific oxidoreductase mycoredoxin-1 (Mrx-1), which reversibly transfers electrons between the mycothiol redox couple (MSH/MSSM) and thiol groups of roGFP2 \[[@R1]\]. Therefore, continuous formation and release of the roGFP2 disulfide bridge is coupled with the actual redox potential of the mycothiol buffer inside mycobacteria \[[@R1]\]. The redox state of Mrx1-roGFP2 thiols can be easily detected by measuring fluorescence intensity at 405 nm and 488 nm excitation wavelengths at a fixed emission of 510 nm \[[@R1]\]. An increase or decrease in 405/488 ratio indicates oxidation or reduction of Mrx1-roGFP2 thiols, respectively \[[@R1]\].

We have earlier reported that acidic pH induces reductive-*E~MSH~* in *Mtb* in a WhiB3-dependent manner \[[@R32]\]. Based on this, we envisaged that the influence of WhiB3 on mycobacterial reductive capacity will be more apparent against oxidative or nitrosative stress, wherein an efficient mobilization of mycothiol-reducing system is critical for the survival of *Mtb* \[[@R1],[@R52]\]. To do this, wt *Mtb*, *Mtb*Δ*whiB3*, and *whiB3* C*omp* strains were exposed to various concentrations of CHP. We monitored short (10 min) -- and long (24 and 48 h) term changes in intramycobacterial *E~MSH~* upon CHP treatment. The short-term measurements are required to capture rapid oxidation in *E~MSH~*, while long-term measurements will provide information about the efficiency by which the cellular antioxidant machinery dissipates oxidative stress to restore redox balance \[[@R1]\]. Addition of 10, 50, and 100 μM of CHP to wt *Mtb* cells resulted in a rapid (\~10 min) increase in Mrx1-roGFP2 ratio (405/488 nm), indicating oxidative shift in *E~MSH~* ([Fig. 2B](#F2){ref-type="fig"}). Longer exposure to 10 μM and 50 μM CHP led to a complete recovery from oxidative stress as evident by a substantial decrease in Mrx1-roGFP2 ratio at 48 h post-exposure, suggesting efficient recruitment of anti-oxidant response mechanisms in wt *Mtb* ([Fig. 2C](#F2){ref-type="fig"}). As expected, treatment with higher concentration of CHP (100 μM) induced a greater oxidation and lesser recovery of biosensor at each time point examined ([Fig. 2C](#F2){ref-type="fig"}). In contrast to wt *Mtb*, exposure to 10, 50, and 100 μM of CHP led to a significantly greater oxidative shift in *E~MSH~* of *Mtb*Δ*whiB3* at early time point (10 min) ([Fig. 2B](#F2){ref-type="fig"}). Longer exposure of 10 μM (48 h), 50 μM (24 h and 48 h) and 100 μM CHP (24 h and 48 h) did not lead to recovery from oxidative stress in *Mtb*Δ*whiB3* as compared to wt *Mtb* ([Fig. 2C](#F2){ref-type="fig"}). These findings implicate WhiB3 in orchestrating an efficient antioxidant response in *Mtb*. The *whiB3 Comp* strain displayed redox changes in *E~MSH~* similar to wt *Mtb* upon CHP treatment ([Figs. 2B & 2C](#F2){ref-type="fig"}). Consistent with the CHP data, H~2~O~2~ treatment also induces greater oxidation of biosensor in *Mtb*Δ*whiB3* than wt *Mtb* and *whiB3* Comp strains ([Fig. 2D](#F2){ref-type="fig"}). Whereas wt *Mtb* and *whiB3* Comp showed significant recovery from oxidative stress induced by 5 mM of H~2~O~2~ within 30 min, *Mtb*Δ*whiB3* remained oxidized ([Fig. 2D](#F2){ref-type="fig"}).

Following oxidative stress, we examined dynamic changes in *E~MSH~* of *Mtb* in response to 0.5 mM of acidified NaNO~2~ for 0.5 h, 24 h and 48 h. In contrast to oxidative stress ([Figs. 2B-2D](#F2){ref-type="fig"}), nitrosative stress did not induce any changes in *E~MSH~* of wt *Mtb*, *Mtb*Δ*whiB3*, and *whiB3 Comp* strains at initial time point (30 min) ([Fig. 2E](#F2){ref-type="fig"}). However, at 24 and 48 h, wt *Mtb* demonstrated a modest but significant increase in Mrx1-roGFP2 ratio, whereas a considerably greater increase was observed in case of *Mtb*Δ*whiB3* ([Fig. 2E](#F2){ref-type="fig"}). Numerical assessment of intrabacterial *E~MSH~* at 48 h post-treatment with acidified nitrite revealed *E~MSH~* of − 261 ± 2 mV for wt *Mtb* and \> −240 mV for *Mtb*Δ*whiB3*, confirming a larger oxidative shift in the *whiB3*-deficient strain. As expected, complementation of *whiB3* in *Mtb*Δ*whiB3* prevented excessive oxidation of *E~MSH~* caused by acidified NaNO~2~ ([Fig. 2E](#F2){ref-type="fig"}). Addition of 0.5 mM of NaNO~2~ at a neutral pH (pH 6.6) did not influence the biosensor ratio ([Fig. 2F](#F2){ref-type="fig"}), suggesting the role of RNS produced by acidified NaNO~2~ in perturbing mycobacterial redox balance. Interestingly, exposure to 50 μM ONOO− induces a rapid (within 10--30 min) increase in Mrx1-roGFP2 ratio with a slightly greater increase in *Mtb*Δ*whiB3* as compared to wt *Mtb* and *whiB3* Comp ([Fig. 2G](#F2){ref-type="fig"}).

It has been shown that a direct oxidation of mycothiol (MSH) by peroxides is kinetically slow \[[@R1]\]. Therefore, the relatively fast oxidative shift in *E~MSH~* upon exposure to CHP and ONOO− is likely to be mediated by MSH-dependent peroxiredoxins or peroxidases. In this context, recently a MSH-dependent peroxiredoxin (alkyl hydroperoxide reductase E; AhpE) has been reported to detoxify organic peroxides and ONOO− in *Mtb* \[[@R19]\]. Also, as shown in the case of *Corynebacterium glutamicum,* a yet-to-be-identified MSH-dependent peroxidase (MPx) might mediate degradation of H~2~O~2~ and CHP in *Mtb* \[[@R40]\]. Taken together, our findings confirm the role of WhiB3 in counteracting oxidative and nitrosative stresses commonly encountered by *Mtb* during infection.

2.3. *Mtb* WhiB3 is essential to induce granuloma formation *in vitro* {#S5}
----------------------------------------------------------------------

It has been previously shown that WhiB3 regulates the production of immunomodulatory complex polyketide lipids (*e.g.,* SL-1, PAT/DAT) and secretory proteins (RD-1 antigens, *espA*) in *Mtb* \[[@R11],[@R32],[@R41]\]. Both secretory lipids and proteins play a critical role in host-pathogen interaction, cytokine response, and granuloma formation during TB infection \[[@R15],[@R8]\]. Infection of mice with *Mtb*Δ*whiB3* resulted in the loss of granuloma formation and aberrant cytokine response, indicating a major role of WhiB3 in regulating immunopathology during infection \[[@R41],[@R48]\]. However, to fully understand the potential of WhiB3 in the TB granuloma development, it is vital to examine the consequence of WhiB3 loss on the granuloma formation in human samples. To begin understanding this, we utilized the *in vitro* model for granuloma development using live mycobacteria and peripheral blood mononuclear cells (PBMCs) from humans. It has been shown that lymphocytes in human PBMCs aggregates around infected bacteria to form assembly of micro-granulomas \[[@R34]\]. Furthermore, micro-granulomas are formed specifically in response to *Mtb*, whereas other microbes such as *E.coli* and *S. aureus* did not form these structures when incubated with human PBMCs \[[@R37]\].

To optimize granuloma formation in an *in vitro* model, we infected 1 or 0.6 million human PBMCs with *Mtb* H37Rv at a MOI of 0.001, 0.005, and 0.01 and incubated for 6 or 9 days. As shown in the [Fig. 3](#F3){ref-type="fig"}, human PBMCs tended to form cellular aggregates in the presence of wt *Mtb* at 6 and 9 days post-infection. Furthermore, aggregates were larger with higher number of PBMCs (1 million) infected with greater number of *Mtb* (MOI: 0.01) ([Fig. 3](#F3){ref-type="fig"}). No granuloma development was observed in case of uninfected control samples ([Fig. 3](#F3){ref-type="fig"}). In contrast to wt *Mtb*, infection of human PBMCs (1 million) with *Mtb*Δ*whiB3* showed no tendency of cells to aggregate and form granulomas ([Fig. 4](#F4){ref-type="fig"}). Altogether, human data is in complete agreement with animal findings (mice and guinea pigs) \[[@R32],[@R48]\] and suggest that WhiB3 is a major virulence factor that dictates the outcome of host-pathogen interaction during TB infection.

3. Discussion {#S6}
=============

Canonical regulators of oxidative and nitrosative stress such as OxyR, SoxR, and FNR are absent in *Mtb*. Despite this, *Mtb* is efficient in counteracting ROS and RNS *in vitro*, inside macrophages, and during infection *in vivo*. Furthermore, *Mtb* mounts effective transcriptional responses upon exposure to diverse ROS and RNS stress agents, indicating the presence of redox sensitive transcription factors in sensing and responding to redox stress. To this end, biochemical and genetic studies have clearly recognized the function of DosR/S/T three-component system in sensing NO, CO, and O~2~ through heme cofactor and inducing the expression of \~ 40 genes dormancy regulon \[[@R24]\]. Additionally, serine-threonine kinase, PknH, also phosphorylates response regulator DosR to mediate full induction of DosR regulation upon NO stress \[[@R6]\]. The ability of DosR/S/T system to sense O~2~ and NO was postulated to help *Mtb* in causing disease in the hypoxic environment of non-human primates and in the HIV patients \[[@R31],[@R56]\]. It\'s been speculated that while the DosR/S/T system serves as an extracellular sensor of redox signals such as O~2~ and NO, WhiB3 *via* its 4Fe-4S cluster functions as an intracellular sensor of ROS and RNS. Overlapping function of both of the systems is required for the metabolic adaptation of *Mtb* in response to redox stress during infection \[[@R41]\]. Similar to this, in diverse bacteria, membrane localized ArcAB two-component system coordinates response to hypoxia, ROS, and RNS, whereas OxyR and SoxRS/FNR systems serve as intracellular redox sensors by exploiting thiols and Fe-S cluster redox chemistry, respectively \[[@R17],[@R27],[@R28]\]. Present study makes a clear case for at least one Fe-S cluster protein, WhiB3, in sensing and responding to ROS and RNS stress in *Mtb*. While biochemical studies showed that the 4Fe-4S cluster of WhiB3 interacts with ROS and RNS \[[@R42]\], lack of genetic evidences raised doubts on the role of WhiB3 in coordinating *Mtb* survival under oxidative or nitrosative stress. Since, *whiB3* deficiency was already found to adversely affect *Mtb* survival under acidic stress \[[@R32]\], its role in ROS/RNS stress remain untested. We rest these speculations by providing unambiguous evidence linking the requirement of WhiB3 for survival and maintenance of redox balance in response to ROS and RNS. Agreeing to this, previous studies suggest that *Mtb* harbors acidic pH responsive factors that also provide cross-protection to other host defenses such as ROS, RNS and lysosomal hydrolases \[[@R53]\]. Our data indicate that WhiB3 is one such factor that coordinates survival in response to multitude of physiologically relevant stresses such as low pH, ROS and RNS. Since milder acidity (pH 6.2) is the earliest cue faced by *Mtb* inside naïve macrophages \[[@R50]\], we propose a model which indicates that WhiB3 mediated shift towards more reducing cytoplasm in response to acidic pH and induction of antioxidants machinery, secretory proteins, and virulence lipids \[[@R32]\], adequately prepares *Mtb* to counteract subsequent exposure to toxic ROS and RNS upon immune-activation ([Fig. 5](#F5){ref-type="fig"}). Induction of immuno-modulatory lipids and secretory proteins by WhiB3 are likely to participate in the granuloma formation and blocking phagosomal maturation to facilitate survival of *Mtb in vivo* ([Fig. 5](#F5){ref-type="fig"}). Agreeing to this, *Mtb*Δ*whiB3* showed survival defect inside naïve and activated macrophages \[[@R32]\]. Other WhiB family member, WhiB1 and WhiB6, have also been reported to respond to RNS *via* its 4Fe-4S cluster \[[@R44],[@R8]\]. However, importance of these proteins in protecting *Mtb* and maintaining redox balance upon nitrosative stress remains to be determined.

Development and maintenance of granulomas in the lung is the hallmark of TB infection and is the major host defense against *Mtb.* Conventionally, TB granulomas have been considered host-protective structures to block the spread of infection and reduce bacterial growth. However, newer evidences suggest that nascent granulomas contribute to early mycobacterial growth. This early bacterial growth is dependent upon the ability of uninfected macrophages to efficiently locate and phagocyte-infected macrophages undergoing apoptosis, which lead to rapid, iterative expansion of infected macrophages, seeding of secondary granulomas and systemic dissemination \[[@R13]\]. More-importantly, mycobacterial secretion system RD-1 is crucial for granuloma-mediated expansion and dissemination of infection \[[@R13]\]. *Mtb*Δ*whiB3* showed reduced expression of genes encoding immuno-modulatory lipids and associated with RD-1 locus, and macrophages infected with the mutant showed reduced expression of genes associated with apoptosis, endosomal machinery, cell cycle and cytokine/chemokine \[[@R11],[@R32]\]. Therefore, the reduced lung inflammation/pathology in *Mtb*Δ*whiB3* infected animals \[[@R32],[@R48]\] strongly implicate the role of WhiB3 mediated granuloma formation in subsequent expansion/dissemination of TB infection. Since, the physiology and disease pathology differs considerably between animals and humans, we realized that it is imperative to examine if WhiB3 is required for granuloma development in humans. Our data clearly aligns with the animal data and showed the requirement of WhiB3 in granuloma formation using human PBMCs. The *in vitro* granuloma model is successfully leveraged to examine early changes in gene expression signatures (both host and bacteria) that take place during induction of granuloma formation in response to *Mtb* infection \[[@R18],[@R37]\]. We extended this model to show that it can be exploited to characterize the function of *Mtb* genes associated with modulating host immune responses and pathogenesis. Future experiments will be aimed to determine specific profile of host gene expression and mechanisms influenced by WhiB3 in the human granuloma model.

4. Materials and methods {#S7}
========================

4.1. Culturing *Mtb* strains {#S8}
----------------------------

*Mtb* H37Rv, *Mtb*Δ*whiB3*, and *whiB3 Comp* strains were cultured aerobically in inkwell bottles with shaking at 150 rpm at 37 °C in liquid Middlebrook 7H9 media with 0.05% tween 80, 0.4% glycerol, 1X OADC, or solid 7H11 supplemented with 0.4% glycerol. Appropriate drugs kanamycin (25 μg/mL) or hygromycin (50 μg/mL) were added. For *in vitro* stress experiments, 0.02% tyloxapol (non-hydrozable detergent) was used instead of tween-80.

4.2. Culturing of cell lines and macrophage infections {#S9}
------------------------------------------------------

The mice RAW 264.7 macrophages were maintained in an atmosphere containing 5% CO~2~ at 37 °C in the culture medium recommended by ATCC. 20,000 cells were seeded in 96 well cell culture plate and infected with all three strains at an MOI of 10 for 4 h as described \[[@R22]\], followed by amikacin treatment (200 μg/mL) for 2 h. After 2 h, cells were washed to remove any extracellular bacteria. At specific time points, cells lysed with 0.06% SDS in 7H9 (for growth curves) and N/10 and N/50 dilutions were plated on antibiotic-containing 7H11 plates. CFUs were enumerated by counting after 20--25 days. Statistical analysis was done using unpaired student\'s *t*-test using GraphPad Prism version 6 software.

4.3. Survival assays in presence of CHP and H~2~O~2~ {#S10}
----------------------------------------------------

*Mtb* H37RV, *Mtb*Δ*whiB3*, *whiB3 Comp* cultures were grown at 37 °C in shaker incubator till log phase (OD ~600\ nm~ 0.5--0.8). 10^7^/mL bacteria were seeded in 10 mL 7H9 with 0.05% Ty, 0.4% glycerol and 10% ADS. Appropriate concentration of hygromycin and kanamycin was added to the respective cultures. 7 M CHP stock (Sigma Aldrich) was diluted to 10 mM in 1X PBS and appropriate volumes were added so as to make it 10 μM, 50 μM and 100 μM, respectively. For H~2~O~2~, log phase (OD ~600\ nm~ 0.5--0.8) grown cultures of *Mtb* H37RV, *Mtb*Δ*whiB3*, *whiB3 Comp* were treated with 1 and 5 mM H~2~O~2~ (Merck Life Sciences) for 72 h. Every 24 h, cells were suspended in fresh medium containing 1 or 5 mM H~2~O~2~. Day 0 CFUs were calculated by plating serially diluted strains just before CHP/ H~2~O~2~ addition. Experimental strains were kept at 37 °C in shaker incubator and plated on appropriate antibiotic-containing 7H11 plates at various time points after serial dilution. CFUs were enumerated after 20--25 days of plating. Statistical analysis was done using unpaired student\'s *t*-test using GraphPad Prism version 6 software.

4.4. Survival assays in presence of acidified nitrite and peroxynitrite {#S11}
-----------------------------------------------------------------------

*Mtb* H37Rv, *Mtb*Δ*whiB3*, *whiB3 Comp* cultures were grown at 37 °C in shaker incubator till log phase (OD ~600\ nm~ 0.5--0.8). 10^7^ bacteria were seeded at pH 5.5 in 10 mL 7H9 with 0.05% tyloxapol, 0.4% glycerol and 10% ADS. pH of the media was adjusted using HCl. pH 5.5 adjusted medium was buffered using 100 mM MES. 1 M sodium nitrite solution was made in water. 0.5 mM sodium nitrite was added in +NO samples and same volume of water was added in -NO samples. For OONO- experiment, log phase (OD ~600\ nm~ 0.5--0.8) grown cultures of *Mtb* H37RV, *Mtb*Δ*whiB3*, *whiB3 Comp* were treated with 50 μM of sodium peroxynitrite (Cayman Chemicals) for 72 h. Every 12 h, cells were suspended in fresh medium containing 50 μM of sodium peroxynitrite. Day 0 cells were serially diluted and plated on required antibiotic-containing 7H11-OADC plates. Bacteria were cultured in shaker incubator at 37 °C and plated again at various time points after serial dilution. CFUs were enumerated after 20--25 days of plating. Statistical analysis was done using unpaired student\'s *t*-test using GraphPad Prism version 6 software.

4.5. *In vitro* measurement of mycothiol redox potential (EMSH) using Mrx1-roGFP2 {#S12}
---------------------------------------------------------------------------------

*Mtb* H37Rv, *Mtb*Δ*whiB3*, *whiB3 Comp* cultures were grown in 37 °C shaker incubator (150 rpm) till log phase (OD ~600\ nm~ 0.5--0.8). 10^7^ /mL bacteria were seeded at, 5.5 in 7H9 with 0.02% Ty, 0.4% glycerol and 10% ADS. pH of the media was adjusted using HCl and NaOH. pH 5.5 adjusted medium was buffered using 100 mM MES. For NO stress, bacterial cells at specified density were treated with 0.5 mM sodium nitrite at pH 5.5. For CHP stress, bacterial cells at specified density were treated with 10 μM, 50 μM and 100 μM CHP. For H~2~O~2~ stress, bacterial cells at specified density were treated with 1 mM and 5 mM of H~2~O~2~. For OONO- stress, bacterial cells at specified density were treated with 50 μM of sodium peroxynitrite. At indicated time points, samples were drawn, treated with 10 mM NEM followed by fixation 4% PFA and analyzed by Fluorescence Activated Cell Sorter (FACS) Verse Flow cytometer (BD Biosciences). The ratio of emission (510/10 nm) after excitation at 405 and 488 nm was calculated. Data was analyzed using the FACSuite software. Intramycobacterial *E~MSH~* was measured using Nernst Equation as described earlier \[[@R1]\].

4.6. Infection of human PBMCs with *Mtb* H37Rv and *MtbΔwhiB3* strains {#S13}
----------------------------------------------------------------------

1 million or 0.6 million human PBMCs (Thermo Fisher Scientific) were seeded in 24-well plates and kept at 37 °C CO~2~ incubator. Single cell suspension of *Mtb* strains was made as described earlier \[[@R22]\]. Required MOI of *Mtb* and *Mtb*Δ*whiB3* strains was added, centrifuged at 700 rpm for 5 min, and incubated at 37 °C CO~2~ incubator for 4 h. After 4 h, 200 μg/mL amikacin was added to remove extracellular bacteria. After 2 h, cells were washed thrice and replaced with 10% GlutaMAX RPMI medium. At day 6 and 9 post-infection, cells were processed for may-grünwald giemsa staining.

4.7. May-grünwald giemsa staining protocol {#S14}
------------------------------------------

The plate was centrifuged (at day 6 or day 9) at 700 rpm and fixed with acetomethanol fixative for 10 min at room temperature (RT). After incubation, the fixative was removed, and may-grünwald stain was added and kept for 30 min at RT. May-grünwald stain was removed after 30 min, and washed with giemsa buffer so as to remove excess of may-grünwald stain. 1X giemsa stain was added, incubated at RT for requisite time duration, and washed with 1X PBS. Images were taken at 16× (10× objective with 1.6 zoom), the number of granulomas were counted. Classification of granulomas was done as follows: \< 100 μm-small and \> 100 μm-large.
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![WhiB3 protects *Mtb* from Oxidative and Nitrosative stress. Exponentially grown cells of *Mtb, Mtb*Δ*whiB3* and *whiB3 Comp* strains expressing Mrx1-roGFP2 were exposed to **(A)** 10 μM, 50 μM and 100 μM CHP, **(B)** 1 mM H~2~O~2~, **(C)** 5 mM H~2~O~2~, **(D)** 0.5 mM acidified (pH 5.5) NaNO~2~ and **(E)** 50 μM sodium peroxynitrite (OONO-) and survival was monitored by enumerating CFUs at indicated time intervals. **(F)** Naïve RAW264.7 macrophages were infected with *Mtb*, *Mtb*Δ*whiB3* and *whiB3 Comp* and intramacrophage survival was monitored at indicated time points. Error bars represent SD from the mean. \* p \< 0.05 (as compared to *Mtb*), + (p \< 0.05 as compared to *whiB3 Comp*), and ns (no significant difference). Data are representative of at least three independent experiments.](EMS83574-f001){#F1}

![WhiB3 maintains cytoplasmic redox potential of *Mtb* in response to oxidative and nitrosative stress. **(A)** Schematic representation of Mrx1-roGFP2 oxidation and reduction in response to redox stress. Prx/MPx denotes MSH-dependent peroxiredoxin (*e.g.,* AhpE)/ MSH peroxidase. The graph represents the 405/488 nm ratios change upon oxidation or reduction of Mrx1-roGFP2 in response to oxidative or reductive stress. Exponentially grown cells of *Mtb, Mtb*Δ*whiB3* and *whiB3 Comp* strains expressing Mrx1-roGFP2 were exposed to 10 μM, 50 μM and 100 μM CHP and ratiometric sensor response was measured at **(B)** 10 min and **(C)** at 24 h and 48 h. Similarly, all the strains were exposed to **(D)** 1 mM and 5 mM H~2~O~2~ for 10 and 30 min, **(E)** 0.5 mM NaNO~2~ at pH 5.5 for 30 min, 24 h and 48 h, **(F)** 0.5 mM NaNO~2~ at pH 6.6 for 30 min, and **(G)** 50 μM sodium OONO- and biosensor response was measured using flow cytometry, as described in [Materials and Methods](#S7){ref-type="sec"}. Error bars represent SD from the mean. \* p \< 0.05 (as compared to *Mtb*), + (p \< 0.05 as compared to whiB3 *Comp*), and ns (no significant difference). Data are representative of at least three independent experiments.](EMS83574-f002){#F2}

![*In vitro* Granuloma Formation upon *Mtb* infection. 0.6 and 1 million PBMCs were infected by *Mtb* at MOI of 0.01, 0.005 and 0.001 and stained with May-grünwald giemsa stain at day 6 and day 9 p.i. Granulomas were classified as follows: \< 100 μm clusters were classified as small and \> 100 μm were classified as large granulomas. Images were taken at 16 S objective (10X with 1.6 zoom).](EMS83574-f003){#F3}

![WhiB3 is required for the development of human Granuloma. Image shows granuloma formation upon incubation of 1 million human PBMCs with wt *Mtb* or *Mtb*Δ*whiB3* at MOI 0.01, 0.005 and 0.001. Note that all the aggregates after *Mtb*Δ*whiB3* infection were composed of less than 50 PBMCs (\< 50 μm) and therefore not classified as granulomas. Images were taken 16× (10× with 1.6 zoom).](EMS83574-f004){#F4}

![Model showing the role of WhiB3 in maintaining redox balance and survival in response to acidic pH, ROS, and RNS. In resting macrophages, *Mtb* is exposed to a milder form of acidic, ROS, and RNS stress. We have previously shown that a moderate acidity in the resting phagosomes (pH 6.2) induces a reductive shift in the intrabacterial *E~MSH~* in a *whiB3*-dependent manner. Under these conditions, WhiB3 regulates the expression of virulence genes involved in blocking phagosomal maturation (*e.g.,* polyketides, RD-1 antigens), which allows *Mtb* to thrive in growth permissive environmental conditions. Moreover, secretory antigens and polyketides regulation *via* WhiB3 might be important for the development of granulomas during infection. Additionally, WhiB3 also induces the expression of several genes involved in maintaining redox homeostasis and protection from ROS and RNS. This facilitates *Mtb* persistence during activation of macrophages with IFN-γ, which induces phagosomal-lysosomal fusion to elevate the levels of proton (pH 4.5), ROI, and RNS in the microenvironment. Impaired ability of *Mtb*Δ*whiB3* to maintain cytoplasmic *E~MSH~* and survive in response to acidic pH, oxidative conditions and nitrosative stress, suggest a central role of WhiB3 in regulating redox balance, persistence, and granuloma formation *in vivo*.](EMS83574-f005){#F5}
